This document discusses the treatment of pulmonary arterial hypertension (PAH), including:
- Approved PAH therapies such as endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostanoids.
- The three main pathways involved in PAH pathogenesis.
- Treatment recommendations for PAH associated with congenital heart disease, including the use of PAH-specific therapies.
- Evidence that PAH-specific therapies can reduce mortality in patients with Eisenmenger syndrome.
- Lung transplantation is an option for patients with inadequate response to maximal PAH therapy.
H trattamento dellipertensione arteriosa polmonareguch-piemonte
油
This document discusses the treatment of pulmonary arterial hypertension. Pulmonary arterial hypertension has several underlying causes, with the most common being idiopathic pulmonary arterial hypertension at around 50% of cases. Medications are the primary treatment and work to dilate blood vessels and improve heart function. These include endothelin receptor antagonists, phosphodiesterase type-5 inhibitors, prostanoids, and soluble guanylate cyclase stimulators. In severe cases, lung transplantation may be considered.
Introduction to Programming with C++ 3rd Edition Liang Test Banktoblerleunis
油
Introduction to Programming with C++ 3rd Edition Liang Test Bank
Introduction to Programming with C++ 3rd Edition Liang Test Bank
Introduction to Programming with C++ 3rd Edition Liang Test Bank
The Digital Revolution: A Short History of an Ideology Balbiobrohepner
油
The Digital Revolution: A Short History of an Ideology Balbi
The Digital Revolution: A Short History of an Ideology Balbi
The Digital Revolution: A Short History of an Ideology Balbi
This document discusses the treatment of pulmonary arterial hypertension (PAH), including:
- Approved PAH therapies such as endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostanoids.
- The three main pathways involved in PAH pathogenesis.
- Treatment recommendations for PAH associated with congenital heart disease, including the use of PAH-specific therapies.
- Evidence that PAH-specific therapies can reduce mortality in patients with Eisenmenger syndrome.
- Lung transplantation is an option for patients with inadequate response to maximal PAH therapy.
H trattamento dellipertensione arteriosa polmonareguch-piemonte
油
This document discusses the treatment of pulmonary arterial hypertension. Pulmonary arterial hypertension has several underlying causes, with the most common being idiopathic pulmonary arterial hypertension at around 50% of cases. Medications are the primary treatment and work to dilate blood vessels and improve heart function. These include endothelin receptor antagonists, phosphodiesterase type-5 inhibitors, prostanoids, and soluble guanylate cyclase stimulators. In severe cases, lung transplantation may be considered.
Introduction to Programming with C++ 3rd Edition Liang Test Banktoblerleunis
油
Introduction to Programming with C++ 3rd Edition Liang Test Bank
Introduction to Programming with C++ 3rd Edition Liang Test Bank
Introduction to Programming with C++ 3rd Edition Liang Test Bank
The Digital Revolution: A Short History of an Ideology Balbiobrohepner
油
The Digital Revolution: A Short History of an Ideology Balbi
The Digital Revolution: A Short History of an Ideology Balbi
The Digital Revolution: A Short History of an Ideology Balbi
Global Economic Institutions 1st Edition Willem Mollekoloohgazari67
油
Global Economic Institutions 1st Edition Willem Molle
Global Economic Institutions 1st Edition Willem Molle
Global Economic Institutions 1st Edition Willem Molle
Test Bank for Understanding Abnormal Behavior, 10th Edition : Suedementogge
油
Test Bank for Understanding Abnormal Behavior, 10th Edition : Sue
Test Bank for Understanding Abnormal Behavior, 10th Edition : Sue
Test Bank for Understanding Abnormal Behavior, 10th Edition : Sue
Viva training in ENT preparation for the FRCS ORL HNS 1st ed Edition Wintermunirinkuah
油
Viva training in ENT preparation for the FRCS ORL HNS 1st ed Edition Winter
Viva training in ENT preparation for the FRCS ORL HNS 1st ed Edition Winter
Viva training in ENT preparation for the FRCS ORL HNS 1st ed Edition Winter
Intermediate Accounting Vol 2 Canadian 2nd Edition Lo Test Bankjotinlywood
油
Intermediate Accounting Vol 2 Canadian 2nd Edition Lo Test Bank
Intermediate Accounting Vol 2 Canadian 2nd Edition Lo Test Bank
Intermediate Accounting Vol 2 Canadian 2nd Edition Lo Test Bank
New Methods of Literacy Research 1st Edition Peggy Albersuxhcablende
油
New Methods of Literacy Research 1st Edition Peggy Albers
New Methods of Literacy Research 1st Edition Peggy Albers
New Methods of Literacy Research 1st Edition Peggy Albers
Solution Manual for Intermediate Accounting 3rd Edition by Wahlentiteuxprasil
油
Solution Manual for Intermediate Accounting 3rd Edition by Wahlen
Solution Manual for Intermediate Accounting 3rd Edition by Wahlen
Solution Manual for Intermediate Accounting 3rd Edition by Wahlen
Test Bank for Systems Analysis and Design 8th Edition: Kendallalawamajina
油
Test Bank for Systems Analysis and Design 8th Edition: Kendall
Test Bank for Systems Analysis and Design 8th Edition: Kendall
Test Bank for Systems Analysis and Design 8th Edition: Kendall
Engineering Economy Sullivan Wicks Koelling 15th Edition Test Bankgadevshahma
油
Engineering Economy Sullivan Wicks Koelling 15th Edition Test Bank
Engineering Economy Sullivan Wicks Koelling 15th Edition Test Bank
Engineering Economy Sullivan Wicks Koelling 15th Edition Test Bank
Presentazione della Dichiarazione di Dubai sulle OER alla comunit italiana -...Damiano Orru
油
Osservatorio sullinformation literacy promuove un incontro online organizzato dalla rete Open Education Italia. n occasione della Open Education Week 2025, dal 3 al 7 marzo, la rete Open Education Italia organizza un incontro online dedicato alla presentazione della Dichiarazione di Dubai sulle Risorse Educative Aperte (OER) il 4 marzo 2025. https://www.aib.it/eventi/dichiarazione-dubai-oer-unesco/
9. Situs cardiaco - atriale
≒AS a sx, AD a dx
≒Latrio che riceve le VPs e a sx = AS
≒Latrio che riceve la VCI e a dx = AD
MA
≒questo non 竪 vero se anomalie del situs toracico
o CAV, ventricolo unico.
13. Cioe
Situs addominale, situs toracico, punta del
cuore, e poi connessioni
≒Aorta a sx (SVS)
≒VCI a dx
≒Atrio a dx che riceve la VCI
≒Atrio a sx che riceve le VP
(situs atriale normale)
≒ Destrocardia
Ao
VCI